Mark Christianson sold $22k of NMTC
Business Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp. 30,000 shares at an average of $0.74, traded Sep 5, 2025, filed Sep 9, 2025.
Score components
- +15RoleOfficer
- 0Trade size$22k at market
- +5Share of holdings soldSold 11% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +15.2%, 3m -30.0%, 6m -11.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001709738-25-000010, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 5, 2025 | SOpen-market sale Common Stock | -30,000 | $0.74 | $22k | 231,238 | Sep 9, 2025 |
Related signals
Other insiders at NEUROONE MEDICAL TECHNOLOGIES Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 26Weak | NMTCbuy NEUROONE MEDICAL TECHNOLOGIES Corp | David J. Wambeke Chief Business Officer | $67k 33,333 shares | +20% | |
| 30Weak | NMTCsell NEUROONE MEDICAL TECHNOLOGIES Corp | Mark Christianson Market Development Director | $32k 10,000 shares | -33% | |
| 15Weak | NMTCsell NEUROONE MEDICAL TECHNOLOGIES Corp | Mark Christianson Business Development Director | $11k 15,363 shares | -7% | |
| 15Weak | NMTCsell NEUROONE MEDICAL TECHNOLOGIES Corp | Mark Christianson Business Development Director | $734 917 shares | -0% | |
| 15Weak | NMTCsell NEUROONE MEDICAL TECHNOLOGIES Corp | Mark Christianson Business Development Director | $11k 13,720 shares | -6% | |
| 51Moderate | NMTCbuy NEUROONE MEDICAL TECHNOLOGIES Corp | David J. Wambeke Chief Business Officer | $670k 1,000,000 shares | - | |
| 15Weak | NMTCsell NEUROONE MEDICAL TECHNOLOGIES Corp | Mark Christianson Business Development Director | $5,804 10,000 shares | -4% | |
| 15Weak | NMTCsell NEUROONE MEDICAL TECHNOLOGIES Corp | Mark Christianson Business Development Director | $5,596 8,981 shares | -3% | |
| 15Weak | NMTCsell NEUROONE MEDICAL TECHNOLOGIES Corp | Mark Christianson Business Development Director | $7,306 11,019 shares | -4% | |
| 68Notable | NEUROONE MEDICAL TECHNOLOGIES Corp | Ronald W. McClurg Chief Financial Officer | $100k 200,000 shares | +82% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.